>Go!
NEWS SEARCH

02.15.2019 | Investors

Allergan to Present at The 8th Annual SVB Leerink Global Healthcare Conference

DUBLIN, Feb. 15, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the 8th Annual SVB Leerink Global Healthcare Conference in New York, NY. The presentation will begin at 9:30 a.m. Eastern Time on Wednesday, February 27, 2019.

Allergan plc logo

The presentation will be webcast live and can be accessed on Allergan's Investor Relations website at https://www.allergan.com/investors/events-presentations. The webcast can also be accessed through the following URL: http://wsw.com/webcast/leerink32/agn/

An archived version will be available within approximately one hour of the live presentation and can be accessed at the same location for 90 days.

About Allergan plc

Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical leader. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

Allergan markets a portfolio of leading brands and best-in-class products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and gastroenterology.

Allergan is an industry leader in Open Science, a model of research and development, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. With this approach, Allergan has built one of the broadest development pipelines in the pharmaceutical industry.

Allergan's success is powered by our global colleagues' commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right.

With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day.

For more information, visit Allergan's website at www.Allergan.com.

CONTACTS:

Allergan:


Investors:


Manisha Narasimhan, PhD


(862) 261-7162




Media:


Amy Rose


(862) 289-3072




Lisa Brown


(862) 261-7320

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/allergan-to-present-at-the-8th-annual-svb-leerink-global-healthcare-conference-300796354.html

SOURCE Allergan plc

Media Contacts
Amy Rose
Global Corporate Media Relations
+1 (862) 289 3072
Lisa Brown
Global Corporate Media Relations
+1 (862) 261 7320
Fran DeSena
U.S. Product Media Relations
+1 (862) 261 8820
Mark Marmur
International Communications & Public Relations
+44 7725 758677

For local media contacts in other countries, please visit the relevant country website.

Investor relations:

Christine Chiou
Investor Relations
+1 (862) 261-7396